Analyst Believes Logitech Has Potential Despite Weak H1 2024 Guidance: Issues Upgrade, New Price Target
Morgan Stanley analyst Erik W.
Bristol-Myers Squibb’s Breyanzi Aces Two Lymphoma Studies On Overall Response Rate Endpoint, Plus New Collaboration
Bristol-Myers Squibb Co (NYSE: BMY) announced
What’s Going On With ExxonMobil Stock? Goldman Sachs Analyst Downgrades Oil Giant
Shares of oil giant ExxonMobil Corp (NYSE: XOM) are moving to the downside Monday after Goldman Sachs downgraded the stock.
Here’s what investors need to know.
Loews Q1 Results Tout Improved Hotels Performance, CNA Revenues Reach Record High
Loews Corp (NYSE: L) reported Q1 2023 EPS of $1.61,
European Union’s Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals
The European Union bloc is reportedly negotiating an amended deal with Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) for around 70 million COVID-19 vaccine doses, despite the European public pro
Sanofi In-Licenses Pompe Disease Therapy From Privately-Held Maze Therapeutics For $150M Upfront
Maze Therapeutics has signed an exclusive worldwide license agreement with Sanofi SA (NASDAQ: SNY) for Maze's glycogen synthase 1 (GYS1) program, including clinical candidate MZE001, which is currently in development for the treatment of Pompe disease and
FDA Advisory Committee Votes Favoring Restricted Use Of AstraZeneca/Merck’s Prostate Cancer Drug
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted against AstraZeneca Plc (NASDAQ:AZN) and Merck & Co Inc’s (NYSE:MRK) application seeking approval for…
Deutsche Bank Gears Up For Biggest Expansions In Investment Banking Space Post Credit Suisse Crumble
Deutsche Bank AG (NYSE: DB) is gearing up to capitalize on the growth opportunities post-collapse of its peer Credit Suisse Group AG (NYSE: CS).
Swiping Right On Mastercard: Analysts Swipe Up Price Targets After Stellar Q1 Earnings Beat
Several analysts increased the price target of Mastercard Inc (NYSE:MA) following reporting a strong Q1 earnings beat. BMO Capital raised its price target to…